Atlas Trials

Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT05544227 · COMPLETED

Trial details

NCT number
NCT05544227
Sponsor
Williams Cancer Foundation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2023-02-01
Primary completion
2024-12-10
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.